66 With $1.3 Million. Here Are 3 Hidden Gems to Target

1 hour ago 1

Alex Sirois

Mon, June 29, 2026 astatine 9:51 AM CDT 3 min read

Quick Read

BMY's 17 consecutive dividend raises and VZ's $20B successful yearly escaped currency travel marque some the dependable income anchors of this trio.
Pfizer's escaped currency travel covered lone 93% of its 2025 dividends, its archetypal shortfall since 2023, putting its 6.6% output connected adjacent watch.
Act now: the expert who called NVIDIA successful 2010 conscionable named his apical 10 AI stocks — and Verizon didn't marque the cut. Grab the names FREE today.

At 66 with $1.3 million, the mathematics is straightforward. A 5% blended output throws disconnected astir $65,000 a twelvemonth earlier Social Security. The currency travel underneath these 3 bluish chips is what matters astir for a retiree. I dug into each dividend to spot which ones a 66-year-old tin really trust on.

A close-up representation of a fiscal papers showing concern portfolio details. A ample pastry illustration connected the left, labeled 'Your Current Investment Mix,' displays 4 segments with chiseled patterns. To the right, sections specify antithetic concern strategies, specified arsenic 'Balanced Growth,' listing categories similar 'Growth,' 'Growth and Income,' 'Income,' and 'Cash Equivalents,' each with corresponding patterned fable boxes and a 25% allocation. Smaller pastry charts travel these legends.

Bristol Myers Squibb: Patent Cliff Meets a 41% Payout Ratio

Bristol Myers Squibb (NYSE:BMY) conscionable raised its payout for a 17th consecutive year, backed by 94 consecutive years of dividend payments.

The Growth Portfolio roseate 12% to $6.23B successful Q1 2026, with Eliquis up 16% and Camzyos up 97%. CEO Christopher Boerner said BMY is "off to a bully commencement successful 2026, with archetypal 4th results reflecting sustained momentum." The Legacy publication is shrinking 12% to 16% connected generics, but a 41% payout leaves existent cushion.

Verdict: Safe. Bull case: Growth Portfolio offsets the patent cliff. Bear case: Eliquis exclusivity erodes faster than expected and indebtedness work crowds retired raises.

Pfizer: The 6.6% Yield Is Earned the Hard Way

Pfizer (NYSE:PFE) is the highest yielder here, and the sum is the tightest.

Act now: the expert who called NVIDIA successful 2010 conscionable named his apical 10 AI stocks — and Verizon didn't marque the cut. Grab the names FREE today.

Free currency travel covered conscionable 93% of 2025 dividends, the archetypal shortfall since 2023. Operating currency travel has slid from $32.6B successful 2021 to $11.7B successful 2025. CEO Albert Bourla called 2026 "an important twelvemonth affluent successful cardinal catalysts." Buybacks are paused, with nary anticipated successful 2026, and the $7.0B Metsera obesity woody adds integration risk.

Verdict: Moderate Risk. Bull case: pipeline and obesity bets refill the gross gap. Bear case: LOE resistance widens and FCF stays beneath the payout.